Charged Particles 4 Cancer Therapy (CP4CT)

Annual report to Charity Commission 2024-2025

Charity Name: Charged Particles for Cancer Therapy (CP4CT)

Charity Number: 1207617

Mission: To advance cancer treatment through innovative research and advocacy, focusing on particle-beam therapy and multidisciplinary collaboration.

Purpose and Objectives

CP4CT is committed to improving cancer care by promoting research into advanced radiotherapy techniques, particularly proton and ion-beam therapy. These approaches deliver radiation more precisely to tumours, reducing side effects and improving outcomes. Our objectives include:

  • Supporting research and development of cutting-edge technologies.

  • Educating the public and professionals about particle therapy.

  • Advocating for equitable access to advanced cancer treatments.

Main Achievements

The first year of the charity has been devoted to developing a communication/advocacy and public engagement programme. This has included developing a website and undertaking work with researchers and stakeholders.

Advocacy and Communication

  • Policy Engagement: CP4CT actively contributes to national cancer policy discussions, including through the All-Party Parliamentary Group on Radiotherapy.

  • Public Awareness: Delivered targeted communication strategies via Instagram, Facebook, and Linktree, delivered via: LhARA | Instagram, Facebook | Linktree. Ensuring accessible information for patients and stakeholders.

  • Events: Featured in exhibitions (Great Exhibition and visit to Imperial College of President Macron and the UK science minister) to raise awareness of particle therapy’s potential.

Education and Outreach

  • LhARA Initiative: CP4CT supports the Laser-hybrid Accelerator for Radiobiological Applications (LhARA), a pioneering project combining physics and biology to revolutionize cancer treatment.

    • Educational Content: Published resources such as “The LhARA initiative; how physics can guide biology to deliver better cancer care”. PPD The LhARA initiative: how physics can guide biology to deliver better cancer care

    • Website and Social Media: Developed and maintained platforms to share scientific progress and patient-focused content.

  • Professional Engagement: Collaborated with research bodies (Imperial College, STFC) and industry partners to advance radiobiology and accelerator science.

Impact and Future Plans

  • Secured donations and funding for communication strategies and patient engagement programs.

  • Strengthened partnerships with academic, clinical, and industrial stakeholders.

  • Future focus: Expand educational outreach, develop patient engagement groups, and accelerate research into compact, cost-effective particle therapy systems.

Future Plans

Next year, we will engage in more fundraising work and partnerships